Drug Trial Radar · NCT05478174
Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General Anesthesia
Last checked: Nov 19, 2026Latest source record: Oct 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
400
Actual
Start
Jul 26, 2022
Primary completion
Nov 7, 2023
Study completion Nov 14, 2023
Sponsor
- Lead sponsor
- Haisco-USA Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 28, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To demonstrate HSK3486 0.4/0.2 mg/kg (0.4 mg/kg intravenous \[IV\] slow injection over 30 \[±5\] seconds for the first dose, an additional 0.2 mg/kg if needed) is non-inferior to propofol 2.0/1.0 mg/kg (2.0 mg/kg IV slow injection over 30 \[±5\] seconds for first dose, an additional 1.0 mg/kg if needed) in success of induction of general anesthesia in adults undergoing elective surgery.
Conditions
- General Anesthesia
Interventions
HSK3486Drug
HSK3486 for induction of general anesthesia
PropofolDrug
Propofol for induction of general anesthesia.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Success Rate of General Anesthesia InductionTime frame: From the time of study drug administration to desired depth of anesthesia to MOAA/S≤1 ( up to 5 minutes)
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Shoals Medical Trials, Inc.
Sheffield, Alabama
Arizona Research Center
Phoenix, Arizona
UC Davis Health
Davis, California
Coastal Clinical Research Specialists
Jacksonville, Florida
University of Miami Hospital
Miami, Florida
Gulfcoast Research Institute, Llc
Sarasota, Florida
Phoenix Clinical Research
Tamarac, Florida
ForCare Clinical Research
Tampa, Florida
Rush University Medical Center
Chicago, Illinois
NextStage Clinical Research - Abay Neuroscience Center
Wichita, Kansas
Chesapeake Research Group, Llc
Pasadena, Maryland
Brigham & Women'S Hospital
Boston, Massachusetts
Duke University Health
Durham, North Carolina
University Hospitals Cleveland Medical Center
Cleveland, Ohio
The Ohio State University Wexner Medical Center
Columbus, Ohio
Midwest Clinical Research Center
Dayton, Ohio
Oregon Health & Science University
Portland, Oregon
HD Research
Bellaire, Texas
Hd Research Llc.
Carrollton, Texas
The University of Texas - MD Anderson Cancer Center
Houston, Texas
Urology San Antonio Research
San Antonio, Texas
Endeavor Clinical Trials
San Antonio, Texas
Jbr Clinical Research
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.